Advances in pituitary pathology: Pituitary tumor gene expression profiles

Endocrinologist

Volumn 13, Issue 4, 2003, Pages 347-350

  Lloyd, Ricardo V ^a   Jin, Long ^a   Kobayashi, Ikuo ^a  

^a MAYO CLINIC   (United States)

Author keywords

Adenomas; DNA array; Pituitary; RNA expression

Indexed keywords

CADHERIN; CHROMOGRANIN; CHROMOGRANIN B; FOLATE RECEPTOR; FOLLITROPIN; GROWTH HORMONE; HYALIN; INHIBIN; LUTEINIZING HORMONE; ONCOPROTEIN; ORNITHINE DECARBOXYLASE; PLAKOGLOBIN; PROLACTIN; PROTEIN P27; PROTEIN P57; PROTEIN TYROSINE KINASE; THYROID HORMONE; TRICHOHYALIN; TYROSINE KINASE RECEPTOR; UNCLASSIFIED DRUG; VITAMIN RECEPTOR;

CANCER HORMONE THERAPY; CARCINOGENESIS; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; GENETIC ANALYSIS; HUMAN; HYPOPHYSIS TUMOR; MOLECULAR GENETICS; ONCOGENE; POLYMERASE CHAIN REACTION; PROGNOSIS; REVIEW;

EID: 0042626444     PISSN: 10512144     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TEN.0000084156.76564.46     Document Type: Review

References (35)

1. Schena M, Shalon D, Davis RW, et al. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270:467-470.
2. Shalon D, Smith SJ, Brown PO. A DNA microarray system for analyzing complex DNA samples using two-color fluorescent probe hybridization. Genome Res. 1996;6:639-6645.
3. Kurian KM, Watson CJ, Wyllie AH. DNA chip technology. J Pathol. 1999;187:267-271.
4. Schulze A, Downward J. Navigating gene expression using microarrays - a technology review. Nat Cell Biol. 2001;3:E190-E195.
5. Golub TR, Slonim DK, Tamayo P, et al. Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science. 1999;286:531-537.
6. Alizadeh AA, Eisen MB, Davis RE, et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature. 2000;403:503-511.
7. Perou CM, Sorlie T, Eisen MB, et al. Molecular portraits of human breast tumours. Nature. 2000;406:747-752.
8. Hedenfalk I, Duggan D, Chen Y, et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med. 2001;344:539-548.
9. Bittner M. Molecular classification of cutaneous malignant melanoma by gene expression profiling. Nature. 2000;406:536-540.
10. Alon U, Barkai N, Notterman DA, et al. Broad patterns of gene expression revealed by clustering analysis of tumor and normal colon tissues probed by oligonucleotide arrays. Proc Natl Acad Sci U S A. 1999;96:6745-6750.
11. Kane MD, Jatkoe TA, Stumpf CR, et al. Assessment of the sensitivity and specificity of oligonucleotide (50mer) microarrays. Nucleic Acids Res. 2000;28:4552-4557.
12. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847.
13. Asa SL, Ezzat S. The cytogenesis and pathogenesis of pituitary adenomas. Endocr Rev. 1998;19:798-827.
14. Spada A, Lania A, Ballare E. G protein abnormalities in pituitary adenomas. Mol Cell Endocrinol. 1998;142:1-14.
15. Herman V, Fagui J, Gonois R, et al. Clinical origin of pituitary adenomas. J Clin Endocrinol Metab. 1990;71:1427-1433.
16. Heaney AP, Melmed S. New pituitary oncogenes. Endocr Relat Cancer. 2000;21:174-198.
17. Farrell WE, Clayton RN. Molecular pathogenesis of pituitary tumors. Front Neuroendocrinol. 2000;21:174-198.
18. Lloyd RV. Molecular pathology of pituitary adenomas. J Neurooncol. 2001;54:111-119.
19. Goidin D, Kappeler L, Perrot J, et al. Differential pituitary gene expression profiles associated to aging and spontaneous tumors as revealed by rat cDNA expression array. Endocrinology. 2000;141:4805-4808.
20. Evans CO, Young AN, Brown MR, et al. Novel patterns of gene expression in pituitary adenomas identified by complementary deoxyribonucleic acid microarrays and quantitative reverse transcription-polymerase chain reaction. J Clin Endocrinol Metab. 2001;86:3097-3107.
21. Wood WM, Sarapura VD, Dowding JM, et al. Early gene expression changes preceding thyroid hormone-induced involution of a thyrotrope tumor. Endocrinology. 2002;143:347-359.
22. Tanaka S, Tatsumi K, Okubo K, et al. Expression profile of active genes in the human pituitary gland. J Mol Endocrinol. 2002;28:33-44.
23. Spada A, Beck-Peccoz P. New strategy to solve the etiopathogenetic conundrum of pituitary adenomas. Endocrinology. 2002;143:343-346.
24. Lloyd RV, Jin L, Qian X, et al. Aberrant p27kip1 expression in endocrine and other tumors. Am J Pathol. 1997;150:401-407.
25. Lloyd RV, Erickson LA, Jin L, et al. p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. Am J Pathol. 1999;154:313-323.
26. Kane MA, Portillo RM, Elwood PC, et al. The influence of extracellular folate concentration on methotrexate uptake by human KB cells. Partial characterization of a membrane-associated methotrexate binding protein. J Biol Chem. 1986;261:44-49.
27. Sudimack J, Lee RJ. Targeted drug delivery via the folate receptor. Adv Drug Deliv Rev. 2000;41:147-162.
28. Mathias CJ, Wang S, Waters DJ, et al. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J Nucl Med. 1998;39:1579-1585.
29. Ernestus RI, Rohn G, Schroder R, et al. Activity of ornithine decarboxylase (ODC) and polyamine levels as biochemical markers of malignancy in human brain tumors. Acta Histochem Suppl. 1992;42:159-164.
30. Seiler N, Atanassov CL, Raul F. Polyamine metabolism as target for cancer chemoprevention. Int J Oncol. 1998;13:993-1006.
31. Graham DK, Dawson TL, Mullaney DL, et al. Cloning and mRNA expression analysis of a novel human protooncogene, c-mer. Cell Growth Differ. 1994;5:647-657.
32. Perez-Juste G, Aranda A. The cyclin-dependent kinase inhibitor p27(Kip1) is involved in thyroid hormone-mediated neuronal differentiation. J Biol Chem. 1999;274:5026-5031.
33. Emmert-Buck MR, Bonner RF, Smith PD, et al. Laser capture microdissection. Science. 1996;274:998-1001.
34. Jin L, Thompson CA, Qian X, et al. Analysis of anterior pituitary hormone mRNA expression in immunophenotypically characterized single cells after laser capture microdissection. Lab Invest. 1991;79:511-512.
35. Emmert-Buck MR, Gillespie JW, Paweletz CP, et al. An approach to proteomic analysis of human tumors. Mol Carcinog. 2000;27:158-165.